Business
Placing and Strategic Update
Placing and Strategic Update.
About this update from Nuformix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3048B\n Nuformix PLC\n 07 October 2020\n \n \n \n \n NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW.\n \n \n THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR A SOLICITATION TO BUY SECURITIES IN OR INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL.\n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.\n \n \n \n \n \n For immediate release\n \n \n \n \n \n Nuformix plc\n \n \n (\"Nuformix\", the \"Company\" or the \"Group\")\n \n \n \n \n \n Placing and Strategic Update \n \n \n \n \n \n Cambridge, UK \n \n - 7 October 2020:\n \n Nuformix plc (LSE:NFX), \n a drug re-purposing specialist, is pleased to announce that it has conditionally placed 23,214,285 new Ordinary Shares (the \"Placing Shares\") at 2.8 pence per share (the \"Placing Price\") with certain existing and new investors (the \"Placing\") to raise approximately £0.65 million (before expenses) (the \"Net Placing Proceeds\"). \n \n \n \n \n \n Fundraising Highlights:\n \n \n \n \n \n The Net Placing Proceeds will be used to accelerate business development with focus on the following key areas:\n \n \n \n \n \n o \n Strengthen Group data packages for treating the effects of Covid-19\n \n \n o \n Maximise opportunities for development pipeline especially lead asset, NXP002\n \n \n o \n Recruit a CEO with responsibil...